Key Takeaway: The FDA’s recent discussion paper seeking feedback regarding the regulation of generative AI-enabled medical devices suggests that the FDA has focused on evaluating, monitoring, and regulating such devices…
NIELSEN COMPANY (US), LLC v. TVISION INSIGHTS, INC. Before Dyk, Reyna, and Bissoon (Chief District Judge for U.S. District Court for the Western District of Pennsylvania, sitting by designation). Appeal…
WYETH LLC V. ASTRAZENECA PHARMA. LP Before Lourie, Linn, and Hughes. Appeal from District Court for the District of Delaware. Summary: Patent claims were not enabled because the specification failed…
Ridge Corp., et al. v. Kirk NationaLease Co., et al. Before Dyk, Mayer, and Taranto. Appeal from the United States District Court for the Southern District of Ohio. Summary: A…
Socket Solutions, LLC v. Import Global, LLC Before Moore, Prost, and Seeborg. Appeal from the U.S. District Court for the Southern District of Florida. Summary: A preliminary injunction cannot stand…
Key Takeaway: Energy companies that market their technologies as environmentally friendly should ensure the claims are accurate and consistent with regulatory guidance. Innovation in the energy industry is often driven…
IRONBURG INVENTIONS LTD. v. VALVE CORPORATION Before Chen, Hughes, and Stark. Appeal from the United States District Court for the Western District of Washington. Summary: The Federal Circuit reversed and…
Key Takeaways: Given the territorial limitations of U.S. Patent Claims, patenting technology for in-space repair and assembly of orbital technology can be challenging. The following blog post discusses strategies for…
Key Takeaway: The FDA’s approval of mFLUSIVA may indicate increased commercial and strategic value of mRNA vaccine patents. On August 5, 2026, Moderna announced that the U.S. Food and Drug…
In this episode of Knobbe IP+, Knobbe Martens partners Jarom Kesler and Bryan McWhorter discuss the latest developments in AI and patent eligibility. Sharing insights for both fellow IP practitioners and…
